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Abstract 36 
Sarcoids are the most prevalent equine skin tumours and remain a therapeutic challenge 37 
due to their differing clinical morphology, local aggressive behaviour, and high recurrence 38 
following surgical treatment. In vitro, sarcoid derived fibroblasts are invasive and express 39 
matrix metalloproteinases (MMPs), namely MMP-1, -2 and -9.  40 
We hypothesised that the MMPs produced by neoplastic cells play a role in both their 41 
local invasiveness and interaction with the overlying epidermis (picket fence formation). We 42 
therefore undertook a morphological study to investigate the local behaviour and in situ 43 
MMP expression pattern in sarcoids of different clinical types. A total of 43 surgically 44 
excised sarcoids were examined by histology, immunohistology for the expression of MMP-45 
1, -2 and -9, and transmission electron microscopy. 46 
Regardless of the clinical type, sarcoids showed local invasion of the dermis and 47 
damage to the basement membrane in areas of interaction with the epidermis. This was 48 
associated with MMP-1 expression in both neoplastic cells and epidermis. These results 49 
suggest a link between MMP-1 expression and the local aggressiveness of sarcoids regardless 50 
of the clinical type. 51 
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Introduction 58 
Sarcoids are the most common equine skin tumours worldwide. A prevalence between 59 
1 and 8% (Knottenbelt, 2005) and a predilection for younger animals have been reported 60 
(Torrontegui and Reid, 1994). Sarcoids develop after inoculation of fibroblasts with bovine 61 
papillomavirus types 1 and 2 (BPV-1, -2) and viral transcription (Bogaert et al., 2007; Hartl 62 
et al., 2011).  63 
Sarcoids can typically be recognised clinically and histopathologically (Marti et al., 64 
1993; Knottenbelt, 2005). With inconclusive histopathological features, PCR from superficial 65 
swabs, skin scrapings or the tumour mass can be helpful (Martens et al., 2000; Martens et al., 66 
2001a).  67 
Six clinical types with individual growth characteristics and local behaviour are 68 
described.  These include occult, verrucose (‘warty’), nodular, fibroblastic, mixed and 69 
malignant forms (Knottenbelt, 2005).  Focal dermal accumulations of fibroblastoid cells, 70 
usually in association with hyperplasia, hyperkeratosis and rete peg formation (RPF) of the 71 
overlying epidermis are typical histological features. Neoplastic cells often show “picket 72 
fence” alignment along the epidermis and are generally locally invasive (Marti et al., 1993; 73 
Martens et al., 2000; Scott and Miller, 2003). The latter possibly accounts for the high 74 
recurrence rate of up to 50%, and the progression from milder forms to the more aggressive 75 
types (Knottenbelt, 2005; Martens et al., 2001b; Marti et al., 1993).  76 
BPV alters the expression of several genes in transformed fibroblasts. Upregulation of 77 
the chemokine CXCL5 indicates an inflammatory response which is assumed to facilitate 78 
sarcoid growth/invasion. Concurrent downregulation of immune response genes, such as 79 
TLR-4 and MHC-I, likely enables viral infection and persistence (Yan et al., 2008a; Yuan et 80 
al., 2010a). Interestingly, matrix metalloproteinase-1 (MMP-1) and -9 are also markedly 81 
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upregulated. MMPs may be responsible for tumour invasiveness since their expression and 82 
BPV-1 infection supports fibroblast invasion in vitro (Yan et al., 2008a; Yuan et al., 2010b). 83 
We aimed to assess local tumour behaviour and in vivo MMP expression in naturally 84 
occurring sarcoids using histology, immunohistological detection of MMP-1, -2 and -9, and 85 
transmission electron microscopy (TEM).  86 
 87 
 88 
Materials and methods 89 
Animals and tissues 90 
Forty-three naturally occurring surgically excised sarcoids from 25 horses (13 geldings, 91 
each 4 stallions and mares, 4 gender unknown) of various breeds and ages (2-21 years; 92 
average: 9.6 years) were studied. The tumours derived from various anatomic sites including 93 
the face, abdominal wall, axilla and medial thigh. None had been subjected to previous 94 
treatment. Individual lesions were  classified clinically (Knottenbelt, 2005) and were 95 
histologically confirmed.  96 
Immediately after surgical excision representative samples were fixed in 10% non-97 
buffered formalin for 1-3 days and routinely paraffin wax embedded. From selected 98 
specimens, a portion was trimmed into 1-2 mm thick slices and fixed in 4% 99 
paraformaldehyde (pH 7.4) with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at 100 
4°C for TEM. 101 
Control skin samples from two horses euthanised for reasons other than skin disease, 102 
were similarly prepared.  103 
 104 
Histology and immunohistology  105 
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Consecutive sections (3-5µm) were prepared from paraffin wax embedded specimens 106 
and stained with haematoxylin and eosin (HE), Gomori Trichrome stain and Periodic Acid 107 
Schiff (PAS) reaction to highlight collagen and the epidermal basement membrane, 108 
respectively. 109 
Immunohistology was used to demonstrate MMP-1, -2 and -9 and, in selected cases, 110 
cytokeratins (to highlight any potential tumour cell invasion into the epidermis), using cross 111 
reacting antibodies: rabbit anti-human MMP-1 (Ab-6), mouse anti-human APMA-activated 112 
native MMP-2 (clone A-Gel VC2), and mouse anti-human native MMP-9 (clone IIA5) 113 
(Thermo Fischer Scientific Anatomic Pathology, Runcorn, UK), all reacting with both the 114 
inactive and the active form of the enzymes, and mouse anti-human pan-cytokeratin (clone 115 
AE1/AE3; Dako, Glostrup, Denmark). The peroxidase anti-peroxidase method with antigen 116 
retrieval in heated citrate buffer (pH 6.0; MMP-1, MMP-9) or protease (cytokeratin) and the 117 
horseradish peroxidase method (Envision; Dako) without antigen retrieval (MMP-2) were 118 
applied (Kipar et al., 1995; Kipar et al., 2005). . Antibody binding was visualised with 119 
diaminobenzidine as chromogen, followed by Papanicolaou’s haematoxylin counterstain.  120 
Consecutive sections incubated with TBS-Tween and/or a non-reacting antibody 121 
against Feline Coronavirus and/or Toxoplasma gondii instead of the primary antibody served 122 
as negative controls. 123 
Constitutive MMP expression in the normal skin was assessed on the two control skin 124 
specimens stained for the MMPs. A biopsy from an inflamed skin wound served as positive 125 
control for the markers. 126 
 127 
Grading and statistical analysis 128 
For MMP-1, the staining intensity of the neoplastic cells was scored over a scale from 129 
faint [(+); 0.5] to strong [+++; 3]. Where staining intensity varied between tumour areas, an 130 
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average was calculated from the range of scores (Table 1). The association between MMP-1 131 
expression intensity and sarcoid clinical type was analysed using Kruskal-Wallis since the 132 
data were not normally distributed and there was no appropriate transformation. Mann-133 
Whitney test was used to compare the sarcoid types pair-wise and the associations of MMP-1 134 
expression with histopathological findings (picket fence formation (PFF), EH, RPF). A 135 
Bonferroni correction was applied post-hoc so results for the three pairwise compared groups 136 
are at  0.167 level of significance. The two types only existing as single samples (mixed and 137 
occult) were excluded from the analysis. Stata 13 (StataCorp) software was used for 138 
statistical analyses.   139 
 140 
Transmission electron microscopy 141 
Local tumour cell behaviour was assessed by TEM on case 14b with epidermal RPF, 142 
cases 12 and 16 with PFF and case 13b with dermal infiltrative growth. Tissue blocks (2 143 
mm3) were prepared from the fixed specimens, post-fixed in 1% osmium tetroxide(aq) and 144 
routinely resin embedded. Toluidine blue stained semi-thin sections (0.75µm) identified areas 145 
of interest from which ultrathin sections (80 nm) were subsequently prepared and examined. 146 
 147 
 148 
Results 149 
Clinical information, classification and histological features of sarcoids  150 
Sarcoids were clinically classified as nodular (n=19), verrucose (n=11), fibroblastic 151 
(n=11), occult (n=1) and mixed (n=1) (Table 1). They presented typical histological features 152 
and were variably cellular, non-demarcated aggregates of spindle shaped fibroblastoid cells in 153 
an irregular collagenous stroma (Martens et al., 2000; Scott and Miller, 2003).  154 
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In 37 cases, intact epidermis at least partly covered the neoplastic infiltrate. It exhibited 155 
epidermal hyperplasia (EH; n=24), RPF (n=20), and/or PFF (n=32), and appeared unaltered 156 
in only 3 nodular sarcoids. PFF was always present in the verrucose and fibroblastic sarcoids 157 
(Table 1A, B).  In verrucose sarcoids, RPF occurred only alongside EH (2/6). Nodular 158 
sarcoids always showed EH together with both RPF and PFF, but either both (2/6) or none 159 
(4/6) of the latter without EH (Table 1). 160 
 161 
Expression of MMP-1, -2 and -9 in the skin and in sarcoids 162 
The normal skin showed intense constitutive MMP-1 expression, represented by a 163 
diffuse cytoplasmic reaction in epithelial cells of epidermis, hair follicles and adnexal glands, 164 
in vascular and arrector pili smooth muscle cells, and in endothelial cells (Fig. S1A). In 165 
contrast, MMP-2 and MMP-9 expression was very weak and limited to epithelial cells (Fig. 166 
S1B, C). Similar MMP expression was generally found in the skin over and around sarcoid 167 
(Fig. 1A). However, epithelial MMP-2 expression was variable, often lacking (n=22) and 168 
sometimes (n=6) slightly more intense than in the control skin.  169 
In all tumours, neoplastic cells expressed MMP-1, evident as a diffuse cytoplasmic 170 
staining (Fig. 1A). Staining intensities varied, both between specimens and within individual 171 
tumours. Comparison of the overall staining intensity in the larger tumour cohorts showed the 172 
highest mean expression in nodular (2.158) and the lowest in verrucose sarcoids (1.545), 173 
fibroblastic sarcoids showed only a slightly higher average (1.659). Since the MMP-1 174 
expression intensity measurements were not normally distributed, the differences were 175 
examined using non-parametric tests rather than comparison of the means. Kruskal Wallis 176 
test identified significant differences between the different sarcoid types (Kruskal-177 
Wallis:𝜒!.!.:!! = 6.288, p<0.05) while pair-wise testing using Mann-Whitney identified 178 
differences  between the verrucose and nodular sarcoids (Mann-Whitney z=-2.581, p<0.05). 179 
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In many cases, there was evidence of an expression gradient in association with PFF (most 180 
intense close to epidermis; Fig. 1B), (focal) ulceration (strongest reaction in proximity to 181 
ulceration) and granulation tissue formation (strongest reaction in neoplastic cells 182 
intermingled with new vessels; Fig. S2A, B) though this spatial association was not reflected 183 
in the association between the overall presence of PFF and the intensity of MMP-1 184 
expression. In some cases, a weak reaction was also seen in pre-existing fibrocytes and nerve 185 
fibres in the tumour-free dermis, and in the serum. 186 
Univariable non-parametric analysis using Mann-Whitney test identified no significant 187 
association between the intensity of MMP-1 expression and the presence of EH (Mann-188 
Whitney z=0.247, p>0.05), RPF (Mann-Whitney z=-1.723, p>0.05) and PFF (Mann-Whitney 189 
z=1.707, p>0.05).  Because of the lack of normal distribution the analysis does not consider 190 
the effect that the different histopathological features may have on the expression of the 191 
MMP-1 or the clustering effect of the origin of some sarcoids from the same animal. 192 
Multivariable analysis on a larger sample could help clarify such associations.  193 
Neoplastic cells were generally MMP-2 negative. In 10 cases (occult, 2 nodular, 3 194 
verrucose, 4 fibroblastic sarcoids), however, they exhibited very weak MMP-9 expression 195 
(Fig. 1C). 196 
Many cases (17/38 with natural surface; Table 1), and in particular the fibroblastic 197 
(9/10) and nodular (5/15) types exhibited variably extensive ulceration. In 4 tumours, this 198 
was chronic, with marked granulation tissue formation (Fig. S2A). Occasionally, mild 199 
peripheral perivascular mononuclear infiltration was also seen (Fig. S2A). Macrophages 200 
within infiltrates expressed MMP-1 (Fig. S2B), MMP-2 (Fig. S2C) and, occasionally, MMP-201 
9. In areas of early ulceration, keratinocytes were strongly MMP-2 positive (Fig. S2D).  202 
 203 
Local infiltrative growth and interaction between neoplastic cells and epidermis in sarcoids 204 
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Tumour infiltrates were not demarcated. Instead, neoplastic fibroblasts infiltrated the 205 
pre-existing dermal collagenous matrix (Fig. 2A). Within the tumour mass, collagen bundles 206 
were irregular and less densely packed than in the normal dermis  (Fig. 2B) and stained 207 
positively for MMP-1 (Fig. 2C). TEM indicated that they were loosened around neoplastic 208 
cells (Fig. 2D).  209 
Interaction between epidermis and neoplastic cells was indicated by PFF, the 210 
perpendicular alignment of tumour cells along the epidermis (Fig. 3A) without infiltration of 211 
the latter, as confirmed by immunohistology for pan-cytokeratin. PFF was identified in 86% 212 
of cases (32/37) with intact epidermis and in all clinical types (Table 1). In PFF areas, the 213 
dermo-epidermal junction was often obscured, as neoplastic cells and keratinocytes exhibited 214 
equally strong MMP-1 expression (Fig. 3B). The basement membrane (BM) appeared 215 
thickened and/or loosened in the PAS reaction, and in semi-thin sections, interdigitation of 216 
neoplastic cells and keratinocytes in the basal epidermal layer became obvious (Fig. 3C). 217 
TEM showed that the BM was absent in these areas (Fig. 3D). In contrast, the BM was 218 
continuous when PFF was not observed (Fig. 3E, F). In all cases, the dermal collagen 219 
appeared disintegrated where neoplastic cells were present (Fig. 3D, F). 220 
 221 
 222 
Discussion 223 
Equine sarcoids originate from fibroblasts transformed by BPV that acquire the 224 
capacity to invade the extracellular matrix (ECM) through the expression of MMPs (Yuan et 225 
al., 2008b; Yuan et al., 2010b; Hartl et al., 2011). In the present in vivo study, histology, 226 
immunohistology for MMP-1, -2 and -9, and TEM were used to assess  local behaviour and 227 
MMP expression patterns in sarcoids.  228 
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Our study confirms that histology does not allow sub-classification, since all relevant 229 
morphological features are observed in all clinical types (Pascoe and Knottenbelt, 1999; 230 
Martens et al., 2000; Knottenbelt, 2005). Hyperplasia and rete peg formation of the overlying 231 
epidermis (EH, RPF) and interaction of neoplastic cells with the epidermis (PFF) are also 232 
typically found in all types, to varying extent. 233 
Sarcoids are locally aggressive, recur frequently and can progress rapidly from 234 
clinically benign to more aggressive forms (Tarwid et al., 1985; Marti et al., 1993; Martens et 235 
al., 2001b; Knottenbelt, 2005). This is reflected histologically by local infiltrative growth of 236 
the neoplastic cells (Martens et al., 2000) which we found in association with apparent 237 
loosening of the dermal collagen matrix. We observed strong MMP-1 expression by 238 
neoplastic cells and MMP-1 deposition in the ECM; this suggests that MMP-1 contributes to 239 
the ECM changes.  240 
MMP-1 is an interstitial collagenase and is expressed by several cell types, including 241 
fibroblasts, keratinocytes and macrophages; it predominantly degrades collagen III. 242 
Expression is regulated at transcriptional level, and induced, for example, by cytokines and 243 
growth factors (Shapiro, 1998; Westermarck and Kähäri, 1999; Fields, 2013). Produced in an 244 
inactive form, MMP-1 is activated by several enzymes (Kähäri and Saarialho-Kere, 1997; 245 
Westermarck and Kähäri, 1999). In equine sarcoids, MMP-1 is present in its active form 246 
(Yuan et al., 2010b), and its release by neoplastic cells may be responsible for infiltrative 247 
dermal tumour growth, via partial destruction of the ECM, i.e. the cleaving of collagen III. 248 
This indicates increased ECM turnover, and indeed, sarcoids have been shown to exhibit an 249 
overall lower amount of collagen than the normal equine dermis, though an increased and 250 
more organised, fibrous collagen III network (Williams et al., 1982). The fate of the cleaved 251 
collagen III remains unclear, since further degrading requires the gelatinases, MMP-2 and -9 252 
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(Shapiro, 1998; Visse and Nagase, 2003: Fields, 2013), neither of which were found to be 253 
upregulated in the present nor a previous study (Yuan et al., 2010b).  254 
We demonstrated MMP-1 expression in sarcoids by both neoplastic fibroblasts and 255 
epithelial cells, in particular epidermal keratinocytes, and with similar intensity. Assuming 256 
that the active form is present, MMP-1, which can degrade several BM components, could 257 
also be responsible for PFF in sarcoids since it accompanies loss of BM continuity. In support 258 
of this an in vitro study showed that sarcoid fibroblast-derived cells invaded a 3D Matrigel 259 
model composed of several BM components (Yuan et al., 2010b).  260 
The epidermal BM is a thin (<100 nm), but vital interface between basal keratinocytes 261 
and dermis. Its upper lamina lucida and ower lamina densa solidly attach the epidermis to the 262 
dermis. This anchoring system is composed of hemidesmosomes at the basal pole of the basal 263 
keratinocytes, thin anchoring filaments that traverse the lamina lucida, and anchoring fibrils 264 
(composed of collagen VII loops) originating from the lamina densa and extending towards 265 
the dermis, as well as collagen IV and laminin networks which provide the basic scaffolding 266 
of the BM and are linked via nidogen. The keratin filament of the hemidesmosomes binds to 267 
laminin 5 which in turn binds to, among others, collagen VII (McMillan et al., 2003; 268 
Breitkreutz et al., 2013). MMP-1 can degrade laminins and collagen VII; with the destruction 269 
of these two proteins, i.e. the anchoring fibrils and one of the two main networks (Shapiro, 270 
1998; Villone et al., 2008), the BM would lose its normal stable architecture. This could 271 
account for the BM destruction seen with PFF in sarcoids and might also render the skin 272 
overlying the neoplastic infiltrate more vulnerable and liable to ulceration. 273 
The local behaviour of sarcoids differs from malignant tumours that invade the 274 
epidermis, such as human cutaneous melanomas in which MMP-2 and -9 are expressed by 275 
neoplastic cells and degrade collagen IV, thereby destroying the BM scaffolding, (Väisänen 276 
et al., 1996; Chen et al., 2012; Breitkreutz et al., 2013) (). This is not encountered in sarcoids. 277 
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However, MMP-2 is also expressed by hyperproliferative keratinocytes (Krengel et al., 2002) 278 
which are found in the epidermis overlying equine sarcoids (Martens et al., 2000). This may 279 
account for the slight increase in epidermal MMP-2 expression in some of our cases. The 280 
latter was particularly obvious in association with PFF, suggesting that direct contact between 281 
epidermis and fibroblasts is a prerequisite of proliferation (Martens et al., 2000). 282 
Alternatively, BPV-1, found to productively infect the epidermis overlying natural sarcoids 283 
(Brandt et al., 2011), could induce keratinocyte hyperproliferation.  284 
In contrast, the strong MMP-2 expression that we observed in keratinocytes in early 285 
ulceration could result from cytokine and MMP-1 release by inflammatory cells (Kähäri, 286 
1997). Similarly, the pronounced MMP-1 expression of neoplastic cells might result from 287 
local cytokine release with ulceration, granulation tissue formation and PFF (Westermarck 288 
and Kähäri, 1999). 289 
Our observation that normal equine epidermis and follicular and glandular epithelium 290 
constitutively express MMP-1 differs from a previous study (Miragliotta et al., 2008). This 291 
could be due to differences in the detection sensitivity since different antibodies and detection 292 
systems were used.  293 
The equine sarcoid remains a clinical challenge and there remains a high risk of failure 294 
with all treatment methods (Knottenbelt and Kelly, 2000). Invasion is the major constraint to 295 
therapy. The likelihood of recurrence is highest with surgical methods that do not include a 296 
safe margin but the difficulty in defining a safe margin for any individual lesion is a 297 
significant surgical challenge. The likelihood of recurrence is seemingly correlated with the 298 
presence of BPV DNA in the surgical margins (Martens et al., 2001c). Topical and 299 
intralesional chemotherapy options may fail because the tumour extends beyond the reach of 300 
the chemotherapeutic agent (Knottenbelt and Kelly, 2000). This study suggests that, 301 
excluding the malignant form which we have not examined, the risks of invasion are not 302 
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significantly different in any particular sarcoid subtype. Early, pre-emptive, use of 303 
medications that could alter the tendency to invasion through manipulation of MMP-1 304 
expression might provide improved outcomes when they are subsequently treated either 305 
surgically or medically.  306 
 307 
 308 
Conclusions 309 
The present in situ study demonstrates a correlation between the expression of MMP-1 310 
by neoplastic and epithelial cells and the local behaviour of sarcoids. The release of MMP-1 311 
could be responsible for the consistently dermal invasion of the neoplastic cells, through the 312 
degradation of collagen III, and could, through partial destruction of the BM, mediate PFF. 313 
These results which were obtained in all clinical types of sarcoids suggest potential new 314 
approaches for the therapy of sarcoids.  315 
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Table legends 462 
Table 1.  463 
A. Sarcoid cases with clinical type, relevant histological features and intensity of MMP-1 464 
expression. 465 
B. Summary results of the examination for the presence of relevant histopathological features 466 
of the epidermis and  its interaction with the neoplastic cells in the different sarcoid types.    467 
 468 
  469 
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Figure legends 470 
 471 
Fig. 1. MMP-1 and -9 expression in neoplastic cells. PAP method. A. Nodular sarcoid (case 472 
14c) with epidermal hyperplasia. The epidermis (E) shows moderate, the neoplastic cells 473 
(arrows) weak MMP-1 expression. Activated endothelial cells in a vein are also strongly 474 
MMP-1 positive (arrowhead). Bar = 20µm. B. Nodular sarcoid with picket fence formation 475 
(case 9b). MMP-1 is strongly expressed by keratinocytes in the epidermis (E). Neoplastic 476 
cells are diffusely positive, but show the strongest expression intensity close to the epidermis 477 
(arrow). Bar = 50µm. C. Fibroblastic sarcoid (case 23), exhibiting weak MMP-9 expression 478 
by neoplastic cells (arrows). Bar = 10µm.  479 
 480 
Fig. 2. Dermal infiltrative growth. A. Nodular sarcoid (case 11) with picket fence formation. 481 
In the dermis, the neoplastic infiltrate is not demarcated and neoplastic fibroblastoid cells 482 
infiltrate into the adjacent pre-existing collagen rich extracellular matrix (arrows). HE stain. 483 
Bar = 50µm. B. Left: Nodular sarcoid (case 14c). The cells are embedded in loosely arranged 484 
thin collagen strands. Right: Normal dermis, comprised of densely packed wavy collagen 485 
bundles with a few embedded unaltered fibrocytes. Gomori Trichrome stain. Bars = 10µm. C. 486 
Nodular sarcoid (case 4b) with intense MMP-1 expression in neoplastic cells (arrows). There 487 
is also a moderate reaction in the extracelluar matrix (arrowhead). PAP method. Bar = 10µm. 488 
D. Nodular sarcoid (case 13b). Transmission electron micrograph of the dermal neoplastic 489 
infiltrate. Several tumour cells (arrows) with prominent cell projections, infiltrating the pre-490 
exsisting collagen rich extracellular matrix that contains dense bundles of short collagen 491 
fibres (asterisks) which appear loosened around the neoplastic cells. Bar = 5µm. 492 
 493 
19 
 
Fig. 3. Interaction between epidermis and neoplastic cells. A. Fibroblastic sarcoid (case 7) 494 
with picket fence formation (PFF), represented by the perpendicular arrangement and 495 
interdigitation of the subepithelial neoplastic cells with the basal cells of the epidermis 496 
(arrows). HE stain. Bar = 20µm. B. Verrucose sarcoid with PFF (case 8a) with strong MMP-1 497 
expression of both epidermis and neoplastic cells, obscuring the dermo-epidermal junction 498 
(arrows). PAP method. Bar = 20µm. C. Nodular sarcoid with PFF (case 16). The epidermal 499 
basement membrane (BM) appears multifocally lost due to the interdigitation of neoplastic 500 
cells with the basal cells of the epidermis (arrows). Semithin section, Toluidine blue stain. 501 
Bar = 10µm. D. Fibroblastic sarcoid with PFF (case 12). Transmission electron micrograph 502 
(TEM). The basal epithelial cells (BE) of the epidermis are devoid of the BM and show loss 503 
of cell-cell contact (acantholysis; arrows). The subepithelial collagen (asterisks) is 504 
disintegrated and closely apposed to a tumor cell (TC) with its long cell projections. Bar = 505 
2µm. E, F. Nodular sarcoid (case 14b) with rete peg formation, but no PFF. E. Neoplastic 506 
cells are positioned close to the BM, but do not interdigitate with the epidermis (arrows). 507 
Semithin section, Toluidine blue stain. Bar = 10µm. F. TEM. The basal epithelial cells (BE) 508 
of the epidermis exhibit a well defined continuous BM (arrows). The subepithelial collagen 509 
(asterisks) is disintegrated and closely apposed to tumour cells (TC). Bar = 2µm. 510 
 511 
  512 
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Supplementary material (Figures S1 and S2): Figure legends: 513 
Fig. S1. Expression of MMP-1, -2 and -9 in the normal equine skin (control case). A. MMP-1 514 
is moderately to strongly expressed by epithelial cells in epidermis (E), hair follicles (HF) 515 
and sebaceous (SG) and apocrine glands (arrows). In addition, smooth muscle and endothelial 516 
cells in blood vessels (V) as well as the smooth muscle cells of the arrector pili muscles 517 
(arrowheads) show a positive reaction. PAP method. Bar = 50µm. B. MMP-2 expression is 518 
generally very weak and restricted to epithelial cells in epidermis (E), hair follicles (HF) and 519 
sebaceous (SG) and apocrine glands (arrows). HRP method. Bar = 50µm. C. MMP-9 520 
expression is generally weak and seen in epithelial cells in epidermis (E), hair follicles (HF) 521 
and sebaceous (SG) and apocrine glands (arrows). PAP method. Bar = 50µm. 522 
 523 
Fig. S2. Ulceration and granulation tissue formation in sarcoids. A. Fibroblastic sarcoid (case 524 
5) with chronic ulceration, with underlying granulation tissue with numerous new vessels 525 
(arrowheads). Inset: Occult sarcoid (case 24) with focal mononuclear perivascular infiltration. 526 
Bar = 50µm (inset: Bar = 20µm). HE stain. B. Mixed sarcoid (case 3) with extensive 527 
ulceration and granulation tissue formation. MMP-1 is expressed by inflammatory cells and 528 
proliferating fibroblasts in the granulation tissue (arrows) and by endothelial cells forming the 529 
new vessels (arrowheads). Neoplastic cells also exhibit moderate MMP-1 expression. Inset: 530 
Occult sarcoid (case 24). Leukocytes in the mononuclear perivascular infiltrate exhibit 531 
moderate MMP-1 expression. PAP method. Bar = 50µm (inset: Bar = 20µm). C. Fibroblastic 532 
sarcoid (case 5) with ulceration and granulation tissue formation. MMP-2 expression is seen 533 
in infiltrating macrophages in the inflammatory process. Endothelial cells in new vessels 534 
(arrowheads) and neoplastic cells are MMP-2 negative. HRP method. Bar = 50µm. D. 535 
Verrucose sarcoid (case 6) with early ulceration, exhibiting strong MMP-2 expression by 536 
epithelial cells (arrowheads). HRP method. Bar = 50µm.  537 
